Alpha Pro Tech (APT) Director Receives 5,615 RSUs; Ownership Updated
Rhea-AI Filing Summary
David R. Garcia, a director of Alpha Pro Tech Ltd (APT), reported a grant of 5,615 time-based restricted stock units under the company's Omnibus Plan on 09/29/2025. The RSUs vest in full on the first anniversary of the grant date, subject to the Plan and the applicable award agreement. Following the reported transaction, Mr. Garcia beneficially owned 19,768 shares of APT common stock. The Form 4 discloses the award as a non-derivative acquisition at a $0 per-share price, reflecting a compensation grant rather than an open-market purchase.
Positive
- Director awarded 5,615 time-based restricted stock units under the Alpha Pro Tech, Ltd. Omnibus Plan
- RSUs vest in full on the first anniversary of the grant date, creating a clear retention schedule
- Post-transaction beneficial ownership disclosed as 19,768 shares, enhancing transparency
Negative
- None.
Insights
TL;DR: Director received time-based RSUs that vest in one year, modestly increasing insider alignment without immediate dilution.
The reported grant of 5,615 restricted stock units is a routine director compensation mechanism to align management and board interests with shareholders. The RSUs vest in full on the first anniversary, which provides a one-year retention incentive. The transaction is recorded as an acquisition at $0, consistent with compensation awards rather than market transactions. The incremental beneficial ownership of 19,768 shares is disclosed, but the filing does not state the company's total outstanding shares or material financial impact.
TL;DR: This Form 4 reflects a non-cash compensation grant to a director; it is informational and likely immaterial to valuation on its own.
The Form 4 documents a time-based RSU grant under the Omnibus Plan and records the post-transaction beneficial ownership figure. Because the award is disclosed at $0 price, it represents compensation expense for the issuer rather than an open-market acquisition by the director. The filing lacks details on total dilution potential, grant fair value, or company-wide equity compensation expense, so its materiality to investors cannot be fully assessed from this form alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | common stock | 5,615 | $0.00 | -- |
Footnotes (1)
- [object Object]